Vaccination against malaria with live parasites

References

• Miller LH, Baruch DI, Marsh K et al. The pathogenic basis of malaria. Nature415, 673–679 (2002).
   PubMed Web of Science ®Google Scholar
• Christophers SR. The mechanism of immunity against malaria in communities living under hyperendemic conditions. Indian J. Med. Res.12, 273–294 (1924).
   Google Scholar
• Sinton JA. A summary of our present knowledge of the mechanism of immunity in malaria. J. Mal. Inst. Ind.2, 71–83 (1939).
   Google Scholar
• Sergent E, Parrot L, Donatien AL. On the necessity of having a term to express the resistance of carriers of germs to superimposed infections. Trans. R. Soc. Trop. Med. Hyg.18, 383–385 (1925).
   Google Scholar
• Mitchell GF. A note on concomitant immunity in host–parasite relationships: a successfully transplanted concept from tumor immunology. Adv. Cancer Res.54, 319–333 (1990).
   Google Scholar
• Bray RS, Gunders AE, Burgess RW et al. The inoculation of semi-immune Africans with sporozoites of Laverania falcipara (Plasmodium falciparum) in Liberia. Riv. Malariol.41, 199–210 (1962).
   PubMedGoogle Scholar
• Bruce-Chwatt LJ. A longitudinal survey of natural malaria infection in a group of West African adults. Part I. West Afr. Med. J.12, 141–173 (1963).
   PubMedGoogle Scholar
• Weijer C. Another Tuskegee? Am. J. Trop. Med. Hyg.61, 1–3 (1999).
   Google Scholar
• Boyd MF. A review of studies on immunity to vivax malaria. J. Natl. Mal. Soc.6, 12–31 (1947).
   PubMedGoogle Scholar
• Redmond WB. Immunity to human malaria: characteristics of immunity. In: A symposium on human malaria. Boyd MF, Soule MH, Coggeshall LT, Craig CF, Taliaferro WH, Williams LL Jr.(Eds). American Association for the Advancement of Science, Washington DC, USA, 231–238 (1941).
   Google Scholar
• Taliaffero W.H. Immunity to the malaria infections. In: Malariology. Boyd MF (Ed.). Saunders, PA, USA (2) 935 (1949).
   Google Scholar
• Collins WE, Jeffery GM. A retrospective examination of secondary sporozoite- and trophozoite-induced infections with Plasmodium falciparum: development of parasitologic and clinical immunity following secondary infection. Am. J. Trop. Med. Hyg.61, 20–35 (1999).
   PubMed Web of Science ®Google Scholar
• Collins WE, Jeffery GM. A retrospective examination of sporozoite- and trophozoite-induced infections with Plasmodium falciparum in patients previously infected with heterologous species of Plasmodium: effect on development of parasitologic and clinical immunity. Am. J. Trop. Med. Hyg.61, 36–43 (1999).
   PubMed Web of Science ®Google Scholar
• McConkey GA, Waters AP, McCutchan TF. The generation of genetic diversity in malaria parasites. Ann. Rev. Microbiol.44, 479–498 (1990).
   Google Scholar
• Craig A, Scherf A. Molecules on the surface of the Plasmodium falciparum-infected erythrocyte and their role in malaria pathogenesis and immune evasion. Mol. Biochem. Parasitol.115, 129–143 (2001).
   PubMed Web of Science ®Google Scholar
• Marsh K, Howard RJ. Antigens induced on erythrocytes by Plasmodium falciparum: expression of diverse and conserved determinants. Science231, 150–153 (1986).
   PubMed Web of Science ®Google Scholar
• Bull PC, Lowe BS, Kortok M et al. Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria. Nature Med.4, 358–360 (1998).
   PubMed Web of Science ®Google Scholar
• Boyd MF, Kitchen SF. Is the acquired homologous immunity to Plasmodium vivax equally effective against sporozoites and trophozoites? Am. J. Trop. Med.16, 317–322 (1936).
   Google Scholar
• Heidelberger M, Prout C, Hindle JA et al. Studies in human malaria. III. An attempt at vaccination of paretics against blood-borne infection with Plasmodium vivax.J. Immunol.53, 109–112 (1946).
   Google Scholar
• Siddiqui WA. Immunization against asexual blood-inhabiting stages of Plasmodia. In: Malaria Immunology and Immunization. Kreier JP (Ed.). Academic Press, NY, USA, 231–262 (1980).
   Google Scholar
• Russel PF, Mulligan HW, Mohan BN. Active immunization of fowls against sporozoites but not trophozoites of Plasmodium gallinaceum by injections of homologous sporozoites. J. Natl. Inst. Ind.4, 311–319 (1942).
   Google Scholar
• Cohen S, McGregor IA, Carrington S. γ-globulin and acquired immunity to malaria. Nature192, 733–737 (1961).
   PubMed Web of Science ®Google Scholar
• Nussenzweig RS, Vanderberg JP, Most H. Protective immunity produced by the injection of X-irradiated sporozoites of Plasmodium berghei. 4. Dose response, specificity and humoral immunity. Mil. Med.134, 1176–1182 (1969).
   PubMed Web of Science ®Google Scholar
• Richie TL, Saul AJ. Progress and challenges for malaria vaccines. Nature415, 694–701 (2002).
   PubMed Web of Science ®Google Scholar
• Nosten F, Luxemburger C, Kyle DE et al; Shoklo SPf66 Malaria Vaccine Trial Group. Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in Northwestern Thailand. Lancet348, 701–717 (1996).
   PubMed Web of Science ®Google Scholar
• D’Alessandro U, Leach A, Drakeley CJ et al. Efficacy trial of malaria vaccine SPf66 in Gambian infants. Lancet346, 462–467 (1995).
   PubMed Web of Science ®Google Scholar
• Alonso PL, Smith T, Schellenberg JR et al. Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania. Lancet344, 1175–1181 (1994).
   PubMed Web of Science ®Google Scholar
• Valero MV, Amador LR, Galindo C et al. Vaccination with SPf66, a chemically synthesised vaccine, against Plasmodium falciparum malaria in Colombia. Lancet341, 705–710 (1993).
   PubMed Web of Science ®Google Scholar
• Heppner DG Jr, Kester KE, Ockenhouse CF et al. Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research. Vaccine23, 2243–2250 (2005).
   PubMed Web of Science ®Google Scholar
• Bojang KA, Olodude F, Pinder M et al. Safety and immunogenicity of RTS,S/AS02A candidate malaria vaccine in Gambian children. Vaccine23, 4148–4157 (2005).
   PubMed Web of Science ®Google Scholar
• Alonso PL, Sacarlal J, Aponte JJ et al. Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial. Lancet364, 1411–1420 (2004).
   PubMed Web of Science ®Google Scholar
• Snounou G, Grüner AC, Müller-Graf CD, Mazier D, Rénia L. The Plasmodium sporozoite survives RTS,S vaccination. Trends Parasitol.21, 456–461 (2005).
   PubMed Web of Science ®Google Scholar
• Pipano E. Live vaccines against hemoparasitic diseases in livestock. Vet. Parasitol.57, 213–231 (1995).
   Google Scholar
• Dalloul RA, Lillehoj HS. Poultry coccidiosis: recent advancements in control measures and vaccine development. Expert. Rev. Vaccines5, 143–163 (2006).
   PubMed Web of Science ®Google Scholar
• Hoffman SL, Goh LM, Luke TC et al. Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J. Infect. Dis.185, 1155–1164 (2002).
   PubMed Web of Science ®Google Scholar
• Doolan DL, Hoffman SL. The complexity of protective immunity against liver-stage malaria. J. Immunol.165, 1453–1462 (2000).
   PubMed Web of Science ®Google Scholar
• Mellouk S, Lunel F, Sedegah M et al. Protection against malaria induced by irradiated sporozoites. Lancet335, 721–721 (1990).
   Google Scholar
• Scheller LF, Azad AF. Maintenance of protective immunity against malaria by persistent hepatic parasites derived from irradiated sporozoites. Proc. Natl Acad. Sci. USA92, 4066–4068 (1995).
   PubMed Web of Science ®Google Scholar
• Silvie O, Semblat JP, Franetich JF et al. Effects of irradiation on Plasmodium falciparum sporozoite hepatic development: implications for the design of pre-erythrocytic malaria vaccines. Parasite Immunol.24, 221–223 (2002).
   Google Scholar
• Nussenzweig RS, Vanderberg JP, Most H et al. Specificity of protective immunity produced by X-irradiated Plasmodium berghei sporozoites. Nature222, 488–489 (1969).
   PubMed Web of Science ®Google Scholar
• Luke TC, Hoffman SL. Rationale and plans for developing a non-replicating, metabolically active, radiation-attenuated Plasmodium falciparum sporozoite vaccine. J. Exp. Biol.206, 3803–3808 (2003).
   PubMed Web of Science ®Google Scholar
• Wellde BT, Sadun EH. Resistance produced in rats and mice by exposure to irradiated Plasmodium berghei.Exp. Parasitol.21, 310–324 (1967).
   PubMed Web of Science ®Google Scholar
• Waki S, Tamura J, Imanaka M et al.Plasmodium berghei: isolation and maintenance of an irradiation attenuated strain in the nude mouse. Exp. Parasitol.53, 335–340 (1982).
   Google Scholar
• Waki S, Yonome I, Suzuki M. Plasmodium yoelii: induction of attenuated mutants by irradiation. Exp. Parasitol.62, 316–321 (1986).
   Google Scholar
• Corradetti A, Verolini F, Bucci A. Resistenza a Plasmodium berghei da parte di ratti albini precedentemente immunizzati con P. berghei irradiato. Parassitologia8, 133–145 (1966).
   Google Scholar
• Wellde BT, Diggs CL, Anderson S. Immunization of Aotus trivirgatus against Plasmodium falciparum with irradiated blood forms. Bull. World Health Organ.57, 153–157 (1979).
   PubMedGoogle Scholar
• Sadun EH, Wellde BT, Hickman RL Resistance produced in owl monkeys (Aotus trivirgatus) by inoculation with irradiated Plasmodium falciparum.Mil. Med.134, 1165–1175 (1969).
   Google Scholar
• Wellde BT, Ward RA, Ueoka R. Aspects of immunity in mice inoculated with irradiated Plasmodium berghei.Mil. Med.134, 1153–1164 (1969).
   Google Scholar
• Waki S, Uehara S, Kanbe K et al. The role of T cells in pathogenesis and protective immunity to murine malaria. Immunology75, 646–651 (1992).
   Google Scholar
• Briggs NT, Wellde BT. Some characteristics of Plasmodium berghei “relapsing” in immunized mice. Mil. Med.134, 1243–1248 (1969).
   Google Scholar
• Van Dijk MR, Douradinha B, Franke-Fayard B et al. Genetically attenuated, P36p-deficient malarial sporozoites induce protective immunity and apoptosis of infected liver cells. Proc. Natl Acad. Sci. USA102, 12194–12199 (2005).
   PubMed Web of Science ®Google Scholar
• Mueller AK, Camargo N, Kaiser K et al.Plasmodium liver stage developmental arrest by depletion of a protein at the parasite-host interface. Proc. Natl Acad. Sci. USA102(8), 3022–3027 (2005).
   PubMed Web of Science ®Google Scholar
• Mueller AK, Labaied M, Kappe SH et al. Genetically modified Plasmodium parasites as a protective experimental malaria vaccine. Nature433, 164–167 (2005).
   PubMed Web of Science ®Google Scholar
• Snounou G, Beck HP. The use of PCR genotyping in the assessment of recrudescence or reinfection after antimalarial drug treatment. Parasitol. Today14, 462–467 (1998).
   PubMedGoogle Scholar
• Ishino T, Chinzei Y, Yuda M. Two proteins with 6-cys motifs are required for malarial parasites to commit to infection of the hepatocyte. Mol. Microbiol.58, 1264–1275 (2005).
   PubMed Web of Science ®Google Scholar
• Yorke W, Macfie JWS. Observations on malaria made during treatment of general paralysis. Trans. R. Soc. Trop. Med. Hyg.18, 13–44 (1924).
   Google Scholar
• Ciuca M, Ballif L, Vieru M Immunité dans le paludisme expérimental. Arch. Roum. Pathol. Exp. Microbiol.3, 209–229 (1930).
   Google Scholar
• James SP, Nicol WD, Shute PG. Clinical and parasitological observations on induced malaria. Proc. Royal Soc. Med.29, 27–42 (1932).
   Google Scholar
• Sinton JA. The effect of treatment upon the development and degree of immunity acquired in malarial infections. Acta Conv. Tertii Mal. Morbis Pars II,312–325 (1938).
   Google Scholar
• Boyd MF, Matthews CB. Further observations on the duration of immunity to the homologous strain of Plasmodium vivax.Am. J. Trop. Med.19, 63–67 (1939).
   Google Scholar
• Jeffery GM. Epidemiological significance of repeated infections with homologous and heterologous strains and species of Plasmodium.Bull. World Health Organ.35, 873–882 (1966).
   Google Scholar
• Langreth SG, Peterson E. Pathogenicity, stability, and immunogenicity of a knobless clone of Plasmodium falciparum in Colombian owl monkeys. Infect. Immunol.47, 760–766 (1985).
   PubMed Web of Science ®Google Scholar
• Pombo DJ, Lawrence G, Hirunpetcharat C et al. Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum.Lancet360, 610–617 (2002).
   PubMed Web of Science ®Google Scholar
• Beaudoin RL, Strome CPA, Mitchell F et al. Plasmodium berghei: immunization of mice against the ANKA strain using the unaltered sporozoites as antigens. Exp. Parasitol.42, 1–5 (1977).
   PubMed Web of Science ®Google Scholar
• Verhave JP, Meuwissen JHET, Golenser J. Cell-mediated reactions and protection after immunization with sporozoites. Israel J. Med. Sci.14, 611–615 (1980).
   Google Scholar
• Orjih AU, Cochrane AH, Nussenzweig RS. Comparative studies on the immunogenicity of infective and attenuated sporozoites of Plasmodium berghei.Trans. R. Soc. Trop. Med. Hyg.76, 57–61 (1982).
   PubMed Web of Science ®Google Scholar
• Belnoue E, Costa FTM, Frankenberg T et al. Protective T cell immunity against malaria liver stage after vaccination with live sporozoites under chloroquine treatment. J. Immunol.172, 2487–2495 (2004).
   PubMed Web of Science ®Google Scholar
• Bradley-Moore AM, Greenwood BM, Bradley AK et al. Malaria chemoprophylaxis with chloroquine in young Nigerian children I. Its effect on mortality, morbidity and the prevalence of malaria. Ann. Trop. Med. Parasitol.79, 549–562 (1985).
   PubMed Web of Science ®Google Scholar